top of page

Our goal is to discover and develop novel, first-in-class medicines for patients with psychiatric disorders that are poorly addressed by current medications, including substance use disorders and treatment-resistant depression. Our innovative technology platform enables us to exploit targets that require a highly adaptive and specialized approach to drug discovery. With our deep understanding of target biology, combined with highly tailored, cutting-edge discovery technologies, we envision finding novel treatments.
VISION
bottom of page
